Ligand Pharmaceuticals Market Sentiment

SPY737.22+0.58%QQQ656.84+1.51%BTC/USD75,723.21−0.32%DIA513.97−0.06%GLD372.04−0.92%TLT82.22+0.35%

Premium Services

Ligand Pharmaceuticals Inc

LGNDNASDAQ

Trade with Public

$307.52

8.522.85%

Last update: Nov 6, 12:58 PM

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Ligand Pharmaceuticals Market Sentiment - Benzinga

Ligand Pharmaceuticals Market Sentiment

Market sentiment signals for Ligand Pharmaceuticals (LGND): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 15.1% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

12 analysts

Options Flow (P/C)

—

Avg Consensus PT

$303

-1.5%

Highest Price Target

$402

+30.7%

Citigroup

Lowest Price Target

$140

-54.5%

Craig-Hallum

Short Interest

15.1%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Nov 5, 2026	Citigroup	Yigal Nochomovitz—	+30.7%	$397 → $402	Maintained	Buy
Oct 30, 2026	RBC Capital	Douglas Miehm—	+16.1%	$345 → $357	Maintained	Outperform
Sep 25, 2026	Barclays	Glen Santangelo—	+12.2%	$345	Initiate	Overweight
Sep 24, 2026	HC Wainwright & Co.	Joseph Pantginis—	+16.4%	$358 → $358	Maintained	Buy
Sep 23, 2026	Citigroup	Yigal Nochomovitz—	+29.1%	$390 → $397	Maintained	Buy
Aug 14, 2026	Leerink Partners	David Risinger—	+7.3%	$330	Initiate	Outperform
Aug 7, 2026	RBC Capital	Douglas Miehm—	+12.2%	$340 → $345	Maintained	Outperform
Aug 6, 2026	HC Wainwright & Co.	Joseph Pantginis—	+16.4%	$289 → $358	Maintained	Buy
Aug 3, 2026	Oppenheimer	Leland Gershell—	+6.0%	$285 → $326	Maintained	Outperform
Jul 21, 2026	Citigroup	Yigal Nochomovitz—	+25.8%	$387	Reinstates	Buy
Jul 15, 2026	RBC Capital	Douglas Miehm—	+10.6%	$262 → $340	Maintained	Outperform
Jul 9, 2026	B of A Securities	Jason Zemansky—	+26.2%	$266 → $388	Maintained	Buy
Jul 8, 2026	Stifel	Annabel Samimy—	+8.0%	$255 → $332	Maintained	Buy
May 8, 2026	RBC Capital	Douglas Miehm—	-14.8%	$252 → $262	Maintained	Outperform
Apr 30, 2026	HC Wainwright & Co.	Joseph Pantginis—	-6.0%	$243 → $289	Maintained	Buy
Apr 28, 2026	RBC Capital	Douglas Miehm—	-18.1%	$235 → $252	Maintained	Outperform
Apr 15, 2026	Citigroup	Yigal Nochomovitz—	-8.3%	$276 → $282	Maintained	Buy
Apr 14, 2026	HC Wainwright & Co.	Joseph Pantginis—	-21.0%	$239 → $243	Maintained	Buy
Mar 24, 2026	Citigroup	Yigal Nochomovitz—	-10.3%	$270 → $276	Maintained	Buy
Mar 11, 2026	B of A Securities	Jason Zemansky—	-20.7%	$244	Initiate	Buy
Feb 27, 2026	Oppenheimer	Trevor Allred—	-9.9%	$275 → $277	Maintained	Outperform
Feb 24, 2026	HC Wainwright & Co.	Joseph Pantginis—	-22.3%	$231 → $239	Maintained	Buy
Dec 10, 2025	RBC Capital	Douglas Miehm—	-23.6%	$234 → $235	Maintained	Outperform
Dec 10, 2025	Stifel	Annabel Samimy—	-25.2%	$220 → $230	Maintained	Buy
Dec 9, 2025	Citigroup	Yigal Nochomovitz—	-12.2%	$270	Initiate	Buy